The rising incidence rate of chronic diseases and the increasing number of geriatric population have resulted in boosting the Infusion Therapy market.
The Global Infusion therapy market is forecast to reach USD 10.98 Billion by 2027, according to a new report by Reports and Data. Infusion therapy is used to give antibiotics, and life-saving hydration fluids that are administered with the help of IV to care users. In this therapy, the medication is administered with the help of a catheter or a needle. Care providers recommend this therapy when the condition of the patient is severe, unable to swallow, or drug recommended is a biologic response. It is commonly used in hospitals; however, in the present healthcare scenario, it can be administered in outpatient infusion therapy centers or even at home care with the assistance of specially trained nurses. The therapy is usually employed for treating chronic infections or serious conditions when patients do not respond to oral antibiotics. Various initiatives of market players like, acquisition are also supporting the market growth. As an instance, in 2016, ICU Medical Inc. was supposed to acquire Pfizer Inc’s Hospira Infusion Systems Business for USD 1.00 Billion. Such initiatives by market players, along with strengthening their market position, are also propelling the market growth. In regards to the region, Europe is projected to occupy a considerable share of the market. The market share held by the region is attributed to the continuously expanding healthcare sector and rising geriatric population.
Key players of the market mentioned in the report are GlaxoSmithKline plc, Johnson Johnson, Pfizer Inc. Allergan, Plc., AbbVie Inc., Fresenius SE Co. KGaA, B. Braun Melsungen AG., Takeda Pharmaceutical Company Limited., Baxter International Inc., Shire Plc and BioScrip.
Get a sample @ https://www.reportsanddata.com/sample-enquiry-form/2601
The report provides comprehensive assessment of competitive landscape and covers profiling of the key players along with their product portfolios and business strategies. It highlights recent mergers and acquisition, joint ventures, collaborations, partnerships, and product launches and brand promotions among others. The research report is an investigative study providing a conclusive view of the Infusion Therapy business sphere by an in-depth segmentation of the market into key applications, types, and regions.
Infusion Therapy Market Segmentation based on Types:
Disease Type Outlook (Revenue, USD Billion; 2016-2027)
- Cardiovascular diseases
- Cancer
- Infectious disease
- Diabetes
- Nephrology urological disorder
- Inflammatory diseases
- Pain management
- Immune deficiency disorders
- Others
Therapy Type Outlook (Revenue, USD Billion; 2016-2027)
- Inotropic therapy
- Antibiotic viral infusion therapy
- Chemotherapy
- Anti-coagulation infusion therapy
- Anesthesia
- Nutritional therapy
- Blood and blood component infusion therapy
- Others
Product Type Outlook (Revenue, USD Billion; 2016-2027)
- Intravenous sets
- Infusion pumps
- Needleless connectors
- IV cannulas
- Vein imaging devices
- Others
End-user Outlook (Revenue, USD Billion; 2016-2027)
- Hospital
- Clinics
- Ambulatory surgery centers
- Home care
- Others
Request a Order on the report @ https://www.reportsanddata.com/report-pricing/2601
Market Overview:
Pharmaceutical and healthcare industry is expected to register robust revenue growth over the forecast period attributable to increasing implementation of advanced technologies such as AI, IoT, cloud computing, and big data analytics in the healthcare sector. Increasing prevalence of chronic diseases, growing need for efficient healthcare facilities and treatment approach, increasing research and development to develop new drugs and therapies, and rising trend of precision medicine are some other key factors expected to drive market revenue growth over the forecast period. The advent of COVID-19 pandemic has significantly contributed to the growth of pharmaceutical and healthcare industry and driven advancements in telemedicine, telehealth, remote monitoring, and at-home services. Integration of electronic health records, advancements in healthcare information exchange systems, and growth of pharmacovigilance are some other factors expected to drive market growth.
To provide an in-depth analysis of the global Infusion Therapy market with regards to its growth opportunities, production and consumption ratio, supply and demand, and export and import ratio, the market report offers key statistical data across the leading regions of the global Infusion Therapy market.
Key Regions Covered in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, France, Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2601
Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure your queries are solved and the report is customized to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
